Agresta Samuel is Chief Medical Officer of Foghorn Therapeutics Inc.
Person profile
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Foghorn Therapeutics Inc.
13 Sep 23
4
Foghorn Therapeutics Inc.
18 Aug 23
144
Foghorn Therapeutics Inc.
16 Aug 23
4
Foghorn Therapeutics Inc.
30 Jan 23
4
INFINITY PHARMACEUTICALS, INC.
16 Jun 22
4
Foghorn Therapeutics Inc.
28 Jan 22
4
INFINITY PHARMACEUTICALS, INC.
11 Jun 21
4
Foghorn Therapeutics Inc.
1 Feb 21
3
Foghorn Therapeutics Inc.
22 Oct 20
4
INFINITY PHARMACEUTICALS, INC.
18 Jun 20
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Aug 23 | FHTX Foghorn Therapeutics | Common Stock | Sell | Dispose S | No | No | 8.25 | 311,297 | 2.57 mm | 0 |
16 Aug 23 | FHTX Foghorn Therapeutics | Common Stock | Option exercise | Acquire M | No | No | 3.72 | 311,297 | 1.16 mm | 311,297 |
16 Aug 23 | FHTX Foghorn Therapeutics | Stock Option Common Stock | Option exercise | Dispose M | No | No | 3.72 | 311,297 | 1.16 mm | 0 |